A critical breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently disabled in several forms of cancer, https://tornadosocial.com/story7639143/mini-antibodies-restore-the-p53-protein-new-new-approach-for-cancer-management